Products
  Testimonials
  Clinical Reports
  Surgical Applications
  Videos
  Distributors
  FAQ's









 

 

 
 


 

VBAS was born of the desire to eliminate the need to “pull” on brain tissue as this is dangerous with current brain retractors that cause a high local retraction pressure distributed over a limited surface area. The VBAS was designed to eliminate any “pulling” on surrounding tissues in any direction. By their circumferential elliptical design as well as the hemispheric design, there is no need to pull in any direction whatsoever. The limited pressure exerted on the surrounding brain tissue is a neutral one, and we believe is far less than the pressures that cause venous compromise and resultant cerebral damage. The design of the VBAS was to maximize the surface area of displaced brain to reduce the local tissue pressure.

VBAS was also designed to function as an IGS pointer, so that problems related to brain shift due to surgical manipulation might be eliminated. In combination with minimally invasive techniques, the problems of volume shift, cortical shift and target tissue shift are minimized and surgeon confidence in IGS enhanced.

VBAS is simple in design and easy to use. The combination of ease of use, navigational capability and reliability will allow for increased surgeon comfort and confidence in the use if IGS technology.

When will VBAS be used
Does the VBAS have any limitations  
What do you think about VBAS & IGS-supported retractor positioning
What are the safety constraints
What about bleeding, is this a concern
How can I purchase Vycor products
Why the need for these devices  
How does the VBAS (ViewSite Brain Access System) differ from current retractors
What is the VBAS
How was the VBAS developed  
 




When will VBAS be used

The TC device will be impressive for use in posterior fossa tumors such as large acoustic neuromas and meningiomas when an internal decompression approach is used. Because the distal margins of these tumors tend to remain fixed to dura or bone during internal decompression, navigational guidance during removal allows for safety to surrounding structures and prevention of traversal tumor margins inadvertently. The TC device also provides for excellent access for far lateral approaches to the foramen magnum and C1/C2 region in the removal of tumors etc. The small port TC model (12mm) is also ideally suited for removal of intracerebral hematomas, third ventriculostomy, colloid cyst excision etc.

We strongly feel that the small port TC model will compete successfully with endoscopic approaches currently being popularized because it offers both neuronavigational capability and binocular vision by way of a truly minimally invasive approach that stands up to endoscopic claims.

We believe the EC model allows for impressive exposure to lesions around the brain, such as meningiomas (subtemporal, subfrontal, falcine, inferooccipital etc.), posterior fossa aneurysms requiring a subtemporal approach, trans-callosal approaches to intraventricular tumors.

Through further development with additional products in the pipeline, we believe we will for the first time allow for a minimally invasive approach to anterior circulation aneurysms and trans-sylvian approaches to posterior circulation aneurysms to provide both navigational confidence and a better exposure than possible with most large craniotomy, extensive sylvian dissection approaches. The view is truly impressive. The retraction problems that commonly occur after anterior communicating artery aneurysm surgery are also eliminated.

We believe to also be able to offer a significant advantage whereas most aneurysms can be included in the elliptical working channel: in cases where intraoperative aneurysmal rupture occurs, bleeding is contained in the working channel itself, thus preventing diffuse dispersion of subarachnoid blood while the problem is being brought under control. The SF will also provide minimally invasive neuronavigational access to tumors along the base such as sphenoid wing and cavernous meningiomas, large supra-sellar pituitary tumors and craniopharyngiomas.

 



Does the VBAS have any limitations

None, which we can see. The access port can be easily manoeuvred, particularly with IGS capability. The field of view is in fact impressive, and surrounding tissues are nicely visualized through the optically transparent working channel.

Sylvian fissure approaches with the products in the development pipeline provide superior visibility with a smaller craniotomy and greatly reduced risk of retraction injury.

We feel that keyhole surgery is made both safer and simpler with VBAS.
.



What do you think about VBAS & IGS-supported retractor positioning

As far as we know, light does not turn around corners; therefore, most approaches require a direct path to the target. We agree that VBAS will not be able to compete with the flexible endoscope, when such manoeuvrability is required. However, we believe that the improved working channel of the VBAS will make endoscopic use easier when it is required.

We feel most strongly that the ability of an access device to “become” the navigational device, so that both access-without-displacement and navigation occur simultaneously, provides for a “10” in both functionality and safety. Such functionality will remove to a large degree the concerns of neurosurgeons that worry about brain-shift targeting issues in a non-real-time IGS working environment.




What are the safety constraints

The VBAS is made of polished polycarbonate and slides very easily along brain tissue. It does not adhere to tissues, even after prolonged periods of time. Therefore, interposed materials are no longer necessary to protect the brain from adhesion to the access device. We do; however, recommend that the access port be lubricated with saline prior to positioning.

The VBAS is designed for minimally invasive neurosurgery. The field of view is actually quite impressive, as mentioned under the “Does VBAS Have Any Limitations” question, above. The “step-by-step” approach is in fact superior to the standard corticotomy approach. As mentioned above, no retraction or pulling is required during positioning of the TC device. The beauty of the TC device is that it eliminates brain shift, allowing for straight path to the target without lateral displacement of the brain or target. For each centimeter of depth of placement, the amount of brain displacement is far less with the TC device than would be required with standard retraction. A lesion at depth would require a larger corticotomy and definite lateral brain shift with standard retractors.

Meticulous hemostasis is standard of care in brain surgery. As the polished polycarbonate tubular surface does not adhere to the surrounding brain, removal does not cause bleeding, as occurs with the removal of cotton etc. after prolonged periods of time with standard retraction systems.

An advantage by design of the VBAS system is obtained in the optical clarity of the polished polycarbonate so that if hemorrhagic change or bleeding occurs in the surrounding tissue during a procedure, it can be visualized as it happens and addressed immediately. Standard retractors and the foam or cotton materials placed beneath and around them are opaque. When bleeding occurs when they are utilized, it is not seen immediately, and sometimes hemorrhagic change in surrounding brain is not recognized until the end of the procedure when the retractor and materials are removed. Any vessels outside the access device can be plainly seen, whereas they can not be seen with standard opaque retraction systems. As the working port is advanced, oncoming vessels can be seen through the optically clear introducer, and therefore avoided accordingly.

Since the VBAS does not cause overdue brain compression, the need to reposition a standard retractor and “control” local pressure has been alleviated. This should make for a calmer and more confident surgical experience.




What about bleeding, is this a concern

Visualization of bleeding as it occurs is a concern, and is addressed by the optical clarity of the VBAS devices. It allows for an immediate response to the problem when it occurs.
The concept of a distally expandable working channel is a good one, particularly when larger lesions at depth are considered in the subarachnoid space. Such capability could be incorporated in future modifications of VBAS.

Vycor Medical is currently underway with certifying that our products are MRI/MRA compatible. Another design consideration for using polycarbonate rather than metal is that transmission of electrocautery energy is not possible with plastic devices, thus eliminating the possibility of electrical burning of exposed tissues.

The following is a graphed chart of 15 neurosurgeons responses to the following questions:
 

We believe that VBAS will allow those surgeons who avoid brain retraction to prevent brain injury (larger craniotomy, more extensive exposure and dissection) to use a brain access system with improved safety and neuronavigational capability. We also believe that those who avoid neuronavigational technology because of fears of brain-shift targeting issues that occur with standard retraction systems will become more comfortable with VBAS as a method fro using IGS. 

We believe that those surgeons who use IGS will all be in the “10” range once they have had a chance to use the VBAS/IGS integrated devices. This information was obtained by viewing ONLY the SLA prototypes. These neurosurgeons had not tried the VBAS System.

Preplanning results in simplified surgery. When accuracy and targeting doubts are allayed in the minds of doubtful surgeons, IGS utilization will rise.
 





How can I purchase Vycor products

These devices are intended to be used only under the orders of a physician only and cannot be purchased by consumers. Vycor Medical Inc.’s products are used when certain brain procedures need to be performed.




Why the need for these devices

Medical technology is constantly evolving. In the last fifty years alone, we have seen everything from mechanical limbs to artificial hearts to robot-assisted surgery. Every surgeon in their specialty needs devices to simplify already complicated procedures. We are confident that our devices do just that. They were created by surgeons for surgeons.





How does the VBAS (ViewSite Brain Access System) differ from current retractors

Current retractors are often referred to as “blade retractors” or “ribbon retractors.” Independently, they are unable to create clear working channels for procedures. They often need additional products such as cottonoids or gauze to help create a working channel for the surgeon. The VBAS gives the surgeon the capability of using one device that provides access to the surgical site and then instantly becomes a clear working channel upon removing the introducer. It is truly a novel device.





What is the VBAS

The VBAS, ViewSite Brain Access System, is a brain retractor system that was designed to give the surgeon direct access to his surgical site and then simultaneously create a working channel for the surgeon to work within. It is comprised of a series of devices that come in various lengths and diameters to assist the surgeon in reaching various regions of the brain in surgery.





How was the VBAS developed

The VBAS was developed by a neurosurgeon who needed to find a way to simplify his surgeries by gaining access effectively to various regions in the brain. It was born on the idea of “there must be a better way.”

 


 


 

 





 
 
 
 
 

Vycor Medical Inc. © 2010 •   Privacy Policy   •   Terms & Conditions   •   Site Map   •   Investor Relations   •   Contact Us